Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTR6P1 (ACTR6 pseudogene 1) is a pseudogene associated with the ACTR6 gene, which encodes ARP6, an actin-related nuclear protein involved in chromatin remodeling and nucleosome positioning[1][5]. The pseudogene itself does not encode a functional protein and has no established biological or disease role, drug interactions, or biomarker utility. Pseudogenes are typically considered non-functional remnants of genes, unless shown to exert a specific regulatory effect, which has not been reported for ACTR6P1. Important context and clarification: - ACTR6 (not ACTR6P1) is a widely-conserved protein involved in chromatin remodeling, nucleosome binding, gene expression regulation, and has relevance in developmental processes and tumor biology[1][2]. - All functional or disease data in biomedical databases relates to the protein-coding gene ACTR6, not to ACTR6 pseudogene 1. - Pseudogenes like ACTR6P1 are generally not considered therapeutic targets, nor do they have established functions, unless specifically noted. - The name ACTR6P1 matches the convention for a pseudogene, not a true molecular target or receptor.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTR6 pseudogene 1 (ACTR6P1).